Abstract Genomic analyses of Amycolatopsis orientalis ATCC 43491 strain, deposited as a vancomycin producer, revealed the presence of genetic loci for the production of at least 10 secondary metabolites other than vancomycin. One of these gene clusters, which contained a type I polyketide synthase, was predicted to direct the synthesis of novel class of compound, a glycosidic polyketide ECO-0501 (1). Screening of culture extracts for a compound with the predicted physicochemical properties of the product from this locus, led to the isolation of the 13-Oglucuronide of 13-hydroxy-2,12,14,16,22-pentamethyl-28-(N-methyl-guanidino)-octacosa-2,4,6,8,10,14,20,24-octaenoic acid (2-hydroxy-5-oxo-cyclopent-1-enyl)-amide (ECO-0501, 1). The structure, confirmed by spectral analyses including MS, and 1D and 2D NMR experiments, were in accord with that predicted by genomic analyses. ECO-0501 possessed strong antibacterial activity against a series of Gram-positive pathogens including several strains of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). ECO-0501 was chemically modified by esterification (1aϳ1c), Nacetylation (1d) and hydrogenation (1e) in order to explore structure activity relationships (SAR).
Introduction
Drug-resistant bacterial infections are a growing health concern. Resistance has been developed to every major class of antibiotics on the market, and an increasing number of pathogenic bacteria are becoming resistant to multiple classes of antibiotics, thereby limiting treatment options. Hence, there is a renewed urgency for the discovery of new classes of antibiotics for the treatment of drug resistant bacterial infections. To accelerate the discovery of such potential antibacterial candidates from natural resources a new, fast and efficient technology is needed. The genomics of secondary metabolite biosynthesis recently evolved to the point where analysis of the genome of an organism can define its biosynthetic capabilities for secondary metabolites. A genome scanning technique that has been developed in our laboratories, and used with our DECIPHER ® technology to analyze the genomes of actinomycetes for their secondary metabolite biosynthetic genes, greatly reduces the amount of sequencing required to define this capability [1, 2] . This approach not only ascertains the potential of a producing organism, but it provides a handle to detect, isolate and structurally define a specific metabolite. We have demonstrated this approach in the isolation and structural determination of an antifungal Part 3 † ECO-0501, a Novel Antibacterial of a New Class agent, ECO-02301 from Streptomyces aizunensis [3] and three 5-alkenyl-3,3(2H)-furanones from two different Streptomyces species [4] . In this article, we are describing the use of the genome scanning technique [5, 6] to identify and isolate a novel class of antibacterial (ECO-0501) from the Amycolatopsis orientalis ATCC 43491 strain, which was deposited as a vancomycin producer. ECO-0501 possessed strong antibacterial activity against several, broadly resistant, Gram-positive pathogens.
Genomic Analyses Lead to Novel Secondary Metabolites

Results and Discussion
A. orientalis ATCC 43491 was obtained from the American Type Culture Collection where it has been deposited as a vancomycin producer. Genomic analysis of this organism identified at least 10 gene clusters responsible for the biosynthesis of secondary metabolites other than vancomycin. Here we chose one of these to express and characterize the product; viz. a locus dominated by a type I polyketide synthase.
This locus spans approximately 100,000 base pairs of DNA and comprises 27 open reading frames (ORFs). The type I PKS system was predicted to generate a long polyketide backbone containing a polyene chromophore. More than 10 kb was analyzed on each side of the locus and these regions were deemed to contain primary genes or genes unrelated to the biosynthesis of secondary metabolites. The PKS system is composed of ORFs 18 to 23 in the locus, and comprises a total of 12 modules. The order, relative position and orientation of the ORFs representing the proteins of the PKS portion of the biosynthetic locus are illustrated schematically in Fig. 1 one in the biosynthesis of the polyketide chain and phylogenetic analysis of the TE predicted a linear polyketide product (Fig. 2) . Three ORFs (7, 25, 24) in the cluster provided genes coding for enzymes with the capacity to convert arginine into 4-guanidinobutyryl-CoA and to load the activated 4-guanidinobutyryl group onto the loading ACP domain for the first PKS module, thus defining the likely starter unit for the polyketide. Two ORFs (16 and 17) provided the proteins for the synthesis of 5-aminolevulinate and its conversion through a coenzyme A ester to aminohydroxycyclopentenone, which is condensed onto the carboxy terminus of the polyketide chain by the enzyme encoded by ORF 15. This pathway is supported by the fact that our previous antifungal agent ECO-02301 had a similar gene cluster, and the aminohydroxycyclopentenone moiety, found in the asukamycins, was reported formed via intramolecular cyclization of 5-aminolevulinate [7] .
The sugar oxidoreductase encoded by ORF 13 oxidizes D-glucose to form D-glucuronic acid that is subsequently transferred onto a hydroxyl group of the polyketide chain through the action of the glycosyltransferase of ORF 14. As the polyketide chain had only one hydroxyl group, the position of glycosylation is unambiguous. Another gene in the cluster, (ORF 5) encoded an N-methyltransferase, which would transfer a methyl group from S-adenosylmethionine to the secondary nitrogen of the guanidine moiety. The full analysis of the gene cluster led to the prediction of a compound of a new structural class, a glycosidic polyketide containing a rare combination of guanidine, glucuronic acid and aminohydroxycyclopentenone groups (ECO-0501, 1).
To obtain expression of this gene cluster, A. orientalis ATCC 43491 was grown in shaken flasks in a dozen different fermentation media designed for the production of secondary metabolites. At harvest, an equal volume of MeOH was added to the broths, which were then vortexed and centrifuged. The supernatant liquid was then drawn off and concentrated to dryness. The resulting residue was re-suspended in MeOH and subjected to HPLC/MS/UV analyses. A number of these extracts contained a compound with UV absorption l max at 258 nm and a broad, poorly resolved, triple peak centered at 362 nm, and MS peaks at m/z 837.5 (in positive mode) and 835.3 (in negative mode) corresponding to the properties predicted for the polyketide metabolite (ECO-0501, 1). Larger scale fermentations of A. orientalis ATCC 43491 were carried out in the most productive media for this metabolite and the target compound was then isolated by a series of fractionations followed by reversed phase HPLC, or by solid phase extraction (SPE) followed by reversed phase HPLC.
ECO-0501 (1) ]. The 1 H NMR spectrum of 1 displayed fourteen olefinic protons together with five oxygenated methine protons, six methyl groups and nine methylene groups. In depth analyses of the gCOSY together with gHSQC spectra led to the definition of two large segments of the polyketide chain represented by bold line (Fig. 4) with a polyene chromophore. All the double bonds of the polyketide, including the two isolatedones as well as the ones in the polyene system, were considered to be trans-oriented based on the basis of the ketoreductases present in the polyketide synthase system. Indeed, analysis of the ketoreductases enables prediction of the stereoconfiguration of the alcohol (D or L) generated through their enzymatic activity. Subsequent action of the dehydratases will generate a trans-or cis-double bond upon dehydration of a D-or an L-alcohol respectively. All ketoreductases present in the ECO-0501 polyketide system were predicted to generate D-alcohols with the exception of the KR present in module 7, indicating that the only alcohol present in the molecule is in the L stereoconfiguration [8] .
The stereochemistry of carbon 13 as shown in Fig. 3 is based only on the genomic data and that of the glucuronic acid moiety is based on carbon chemical shifts [9] . The stereochemistry of the double bonds was confirmed by the observed coupling constant values (Ͼ14. (Fig. 4) indicated that the sugar was a hexuronic acid. This was further confirmed by the presence of a HMBC cross peak between oxy-methine proton at d 3.41 to carbonyl carbon at d 176.1. The HMBC correlations between anomeric proton and carbon with the C-13 carbon and proton (d C 93.8 and d H 3.58) indicated that this was the point of attachment of the sugar moiety.
The sharp singlet peak of two methylene groups at d 2.35 (d C 31.0) having long range correlation with carbons at d 111.4, 199.3 and 31.0 indicated the presence of aminohydroxycyclopentenone group attached to the carbonyl carbon of the polyketide chain by an amide bond; a similar group to that of an antifungal agent ECO-02301 [3] . Accordingly the structure of ECO-0501 was confirmed, as that predicted by genomic analysis. The compound was further modified into corresponding mono-and di-methyl 
esters (1aϳ1c) by treating with dimethyl sulphate in
MeOH. An N-acetyl derivative (1d) was obtained via acetylation of ECO-0501 with acetic anhydride, while a decatetrahydro derivative (1e) was produced by hydrogenolysis of 1 in the presence of PtO 2 in MeOH.
The compounds were tested for their antibacterial activity against pathogenic strains. The minimal inhibitory concentrations (MICs) are summarized in Table 4 . ECO-0501 (1) possessed significant antibacterial activity against all strains tested. The MIC values were comparable to that of vancomycin, which was used as a control. In low pH (5.0 and 6.0), compound 1 showed stronger antibacterial activity than vancomycin against S. aureus (ATTC 6538P). All the modified products i.e., methyl esters (1aϳ1c), N-acetyl derivative (1d) and decatetrahydro derivative (1e) were less potent against S. aureus (ATTC 6538P) as shown in Table  4 , indicating the importance, for antibacterial activity, of the free acids as well as the polyene chromophore. The decahydroderivative (1e) was inactive to 32 m g/ml in this assay.
Preliminary work aimed at defining the mode of action of ECO-0501 suggested that this compound exerts its bactericidal properties through a potentially novel cell membrane and/or cell wall target specific to bacteria. Furthermore, ECO-0501 displayed efficacy in a mouse model of S. aureus infection when given i.p. (data not shown).
Experimental
General
The NMR spectra were measured on a Varian Unity Inova 500 MHz spectrophotometer with methanol-d 4 . Solutions, and are referenced to TMS. The analytical HPLC was carried out with a Waters Alliance 2690 instrument equipped with a Micromass ZQ electrospray source and Waters 996 diode array UV detectors. Semi-preparative HPLCs were done either on a Waters 1525 instrument with Waters 2996 diode array UV detector or on Waters Autopurification System with At Column Dilution (ACD). All the chemicals and solvents used for the purifications were HPLC grade.
Genome Scanning
The genome of A. orientalis ATCC 43491 was analyzed by genome scanning technique as described previously by Zazopoulos et al. [2] . The DNA and protein sequences that comprise the ECO-0501 gene cluster are deposited in GeneBank under accession numbers Contig1 DQ884174, orientalis ATCC 43491 was grown on ISP2 agar (Difco) for 5 to 7 days, and the surface growth from the agar plate was homogenized and transferred to a 125 ml flask containing three glass beads (5 mm diameter), and 25 ml of sterile medium prepared from trypticase soy broth (Bacto) 30 g, yeast extract 3 g, MgSO 4 2 g, glucose 5 g, maltose 4 g, to which one liter distilled water was added. This vegetative culture was incubated at 28°C for about 60 hours on a shaker with a 2.5 cm throw and set at 250 rpm. The vegetative culture (10 ml aliquots) was used to inoculate 2 liter baffled flasks each containing 500 ml of sterile production medium prepared from glucose 10 g, glycerol 5 g, corn steep liquor 3 g, beef extract 3 g, malt extract 3 g, yeast extract 3 g, calcium carbonate 2 g, thiamine 0.1 g made up to one liter with distilled water [11] . The medium was adjusted at pH 7.0, and then 1 ml of silicon defoamer-oil (Chem Service) was added to each flask before sterilization. The fermentation batches were incubated aerobically on a shaker (200 rpm) at 28°C for a period of 4 days.
Isolation of ECO-0501 (1)
The mycelia and broth of the culture media (12ϫ500 ml) was separated by centrifugation (3000 rpm, 20 min). The mycelial cake was extracted consecutively with methanol (200 ml/liter broth) and acetone (200 ml/liter) to produce an organic cell extract. The organic extract was used for further purification by two different methods.
Method A The combined organic extract was dried under vacuum, and further suspended in a mixture of MeOH/aqueous NH 4 HCO 3 solution adjusted to pH 10 with NH 4 OH (3 : 2, 100 ml/liter original broth volume) and consecutively extracted by CHCl 3 (100 ml/liter) and n-BuOH (100 ml/liter). The BuOH fraction was concentrated, and the residue was dissolved in a minimal amount of DMSO/MeOH (3 : 1) and subjected for HPLC purification after filtering through a 0.45 m m 13 mm Acrodisc GHP syringe filter. The HPLC was performed on a Waters Autopurification System with ACD using a Waters Xterra MS C18 column (5 m , 19ϫ150 mm), and a gradient of 10 mM aqueous NH 4 HCO 3 (pH 10)/acetonitrile 85 : 15 to 25 : 75 over 30 minutes at 19 ml/minute, UV detector set at 261 nm. The semi-purified ECO-0501 (1, 1.04 g), eluting at 11.8ϳ12.1 minutes, was collected.
ECO-0501 (1, 37.4 mg/liter) was purified by repeated HPLC on a Waters Autopurification System with ACD using a Waters RCM Column (Novapak C-18, 6 m , 40ϫ200 mm) with a gradient of 10 mM aqueous NH 4 OAc adjusted to pH 5 with glacial AcOH/acetonitrile from 80 : 20 v/v to 20 : 80 over 25 minutes at 35 ml/minute.
Method B
The combined organic extract, which was dried under vacuum was suspended in a mixture of MeOH and aqueous NH 4 HCO 3 solution adjusted to pH 10 with NH 4 OH (3 : 2, 100 ml/liter) and extracted with hexane (3ϫ100 ml/liter original broth volume) to remove fatty substances. The aqueous methanolic fraction was then adsorbed (slurrymode) on Diaion HP-20 resin (30 ml/liter of fermentation broth) and applied to SPE on a Startat C-18 Cartridge (Phenomenex) with a precolumn of Diaion HP-20 resin (70 ml). The column was subsequently eluted with a step gradient of EtOH/aqueous NH 4 HCO 3 buffer pH 10 to collect one 500 ml fraction and then seven fractions (200 ml each) i.e., 1 : 9 (fraction 1); 1 : 4 (fraction 2); 3 : 7 (fraction 3); 2 : 3 (fraction 4); 1 : 1 (fraction 5); 3 : 2 (fraction 6); 8 : 1 (fraction 7) and EtOH (fraction 8). Fractions 4ϳ7 were pooled, concentrated and the residue was subjected for HPLC (Waters Autopurification System with ACD), using a Symmetry C18 column (5 m , 30ϫ100 mm) with a gradient of 10 mM aqueous NH 4 OAc, (adjusted to pH 5 with glacial AcOH)/acetonitrile 74 : 26 v/v to 50 : 50 over 20 minutes at 39 ml/minute. The collection was triggered by UV absorption at 261 nm (PDA). The sample was loaded as a suspension in DMSO : MeOH (3 : 1). ECO-0501, which eluted at 14.9ϳ15.2 minutes, was pure. C NMR data are in Table  1 .
Synthesis of 1aϳ1c
A solution of 1 (20 mg) in MeOH (2.0 ml) was stirred with a mixture of 0.1 mM NaOH (Fisher Chemicals) solution in MeOH (334 m l) and dimethyl sulfate (5.68 m l, Sigma) at room temperature for 24 hours. The reagents were successively added to the reaction mixture after 24 and 48 hours (NaOH solution 300 and 400 m l; dimethyl sulphate 10 and 15 ml). The reaction was monitored by TLC (Merck Silica gel 60 F 254 , eluted with 7% methanol in chloroform, visualized under UV) and stopped after 72 hours. The reaction mixture was purified by HPLC on a Waters AutoPurification System using a Symmetry column (C-18, 5 m, 30ϫ100 mm) with 10 mM NH 4 Table 2 .
Synthesis of 1d
A solution of 1 (20 mg) in MeOH (2 ml) was stirred with acetic anhydride (20 ml) at room temperature for 24 hours. Additional acetic anhydride (20 m l) was added to the reaction mixture at 24 and 48 hours. The reaction was monitored by TLC (Merck Silica gel 60 F 254 , eluted with 7% MeOH in chloroform, visualized under UV) and stopped at 72 hours.
The reaction mixture was purified by HPLC on a Waters Auto-Purification System using a Symmetry (C-18, 5 m , 30ϫ100 mm) column with 10 mM NH 4 Table 2 .
Synthesis of 1e
A solution of 1 (20 mg) in MeOH (2 ml) was stirred under hydrogen gas overnight at room temperature in the presence of PtO 2 (10 mg) as a catalyst. The reaction mixture was filtered and the filtrate was concentrated to obtain the decatetrahydro derivative (1e, 18.7 mg). C NMR data are in Table 2 . [12] .
Antibacterial Activity
The stock solutions of the tested compounds were prepared in DMSO (100ϫ) and diluted with MuellerHinton test medium as two-fold series over 11 points from 3.2 mg/ml to 0.003 mg/ml. An aliquot of each stock solution was diluted 50-fold in test medium described below to give a set of eleven 2ϫ solutions. Fifty microliters of each of the eleven 2ϫ solutions were aliquoted into the corresponding wells of a 12-well row, with the final well reserved for a medium-alone control. Vancomycin (Sigma) used as positive control, which was prepared as 2ϫ stock solutions in Mueller-Hinton test medium ranging from 64 mg/ml to 0.06 mg/ml (a two-fold dilution series over 11 points). An aliquot of 50 ml of each concentration (at 2ϫ) was then transferred to 96-well microplates to obtain a series of eleven two-fold dilutions.
An isolated colony of each of the eight indicator strains was used to inoculate tubes containing 2 ml of test medium. Mueller-Hinton test medium was used for S. aureus (ATCC 6538P), S. aureus MRS3 (ATCC 700699), S. epidermidis (ATCC 12228), B. subtilis (ATCC 23857), B. megaterium (ATCC 14581) and M. luteus (ATCC 9341) indicator strains, and Brain Heart Infusion test medium was used for E. faecalis VRE-1 (ATCC 29212) and E. faecalis VRE-2 (ATCC 51299) indicator strains. Cells were grown overnight at 35°C with shaking. Inoculum density for each indicator strain was adjusted to OD 600 ϭ0.1 in 5 ml 0.85% saline, then further diluted 1/100 in appropriate medium. 50 ml of the final dilution (in test medium) of each indicator strain was added to each well of a 12-well row. This brings the final dilution of the test compound or control compound in solution to 1ϫ. The final inoculum has approximately 5ϫ10 5 CFU/ml. The indicator strains were incubated with 11 concentrations of each of test compounds, vancomycin (Sigma) control and one medium-alone control. For MIC determination, assay plates were incubated at 35°C for 16 to 20 hours. The MIC for each indicator was assessed as the lowest concentration of the compound resulting in total absence of growth and is shown in Table 3 .
